Silence Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $159 | $224 | $142 | $24,327 |
Gross Profit | 95 | 139 | 88 | 22,721 |
EBITDA | -20,801 | -22,491 | -28,271 | 7,192 |
EBIT | -20,957 | -22,639 | -28,409 | 7,073 |
Net Income | -20,958 | -27,354 | -28,530 | 14,174 |
Net Change In Cash | 159 | 224 | 142 | 24,327 |
Free Cash Flow | -10,894 | -21,832 | -12,313 | -24,920 |
Cash | 82,031 | 41,739 | 64,886 | 121,330 |
Basic Shares | 15,744 | 15,744 | 15,742 | 47,224 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43,258 | $25,375 | $21,655 | $12,415 |
Gross Profit | 31,448 | 15,057 | 8,192 | 4,959 |
EBITDA | -48,989 | -49,778 | -60,444 | -45,421 |
EBIT | -49,582 | -50,276 | -61,040 | -45,848 |
Net Income | -45,309 | -43,267 | -50,334 | -39,410 |
Net Change In Cash | 43,258 | 25,375 | 21,655 | 12,415 |
Free Cash Flow | -67,851 | -39,395 | -57,589 | 7,385 |
Cash | 121,330 | 68,789 | 54,816 | 73,537 |
Basic Shares | 15,416 | 12,364 | 10,731 | 29,650 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.15 |
2025-06-30 | -$0.55 |
2025-03-31 | -$0.60 |
